Sinovac Biotech (SVA) Reports Q2 Loss of $0.17

August 23, 2016 6:08 AM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Sinovac Biotech (NASDAQ: SVA) reported Q2 EPS of ($0.17), versus $0.04 reported last year. Revenue for the quarter came in at $1.38 billion, versus $18.49 billion reported last year.

For earnings history and earnings-related data on Sinovac Biotech (SVA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment